ShangPharma Investment Group

ShangPharma Innovation operates as a venture capital firm and incubator, specializing in early-stage investment and development within healthcare and life sciences. The firm provides capital and strategic support to emerging companies, research laboratories, and medical centers. It focuses on novel biomedical research and development technologies and therapeutics, fostering advancements from initial stages to solutions.

Established in 2016, ShangPharma Innovation originated as a strategic investment division of the ShangPharma Group. This move leveraged the Group's established expertise in pharmaceutical and biotechnology research, extending its influence into venture investment. Its formation reflects a commitment to nurturing innovation, with Walter H. Moos appointed Chief Executive Officer.

The firm empowers its portfolio companies, scientific founders, and research institutions with vital funding and expert guidance. ShangPharma Innovation's mission is to accelerate scientific discoveries into viable therapeutic solutions. Its vision centers on making substantial contributions to global healthcare by driving the development of groundbreaking biomedical technologies.